A. Guzman

The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis.

L. Davis, E. Frohman, G. Remington, 2014, JAMA neurology.

B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses

E. Frohman, N. Monson, Sara J Ireland, 2016, Journal of Neuroimmunology.

A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients

W. Robinson, E. Meinl, E. Frohman, 2015, ASN neuro.

Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients

Ann M. Stowe, L. Cowell, E. Meffre, 2016, Acta Neuropathologica.

Effects of Carbapenem Exposure on the Risk for Digestive Tract Carriage of Intensive Care Unit-Endemic Carbapenem-Resistant Pseudomonas aeruginosa Strains in Critically Ill Patients

C. Suárez, J. Ariza, F. Tubau, 2007, Antimicrobial Agents and Chemotherapy.

The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis.

L. Davis, E. Frohman, G. Remington, 2014, JAMA neurology.